
Dr. Sanborn is a clinical cardiologist and a specialist in Cardiac Ultrasound/Echocardiography. She also serves as the Medical Director of the Paul Dudley White Associates Cardiology Fellows' Practice.
Specialties
BiographyDr. Sanborn received her MD degree from the University of Iowa College of Medicine in 1995. She completed residency training in Internal Medicine and fellowship training in Cardiovascular Disease with an advanced fellowship in Echocardiography at Massachusetts General Hospital. She joined the faculty in the Cardiology Division at MGH and Harvard Medical School in 2002. During her fellowship, she also completed Harvard Medical School's Scholars in Clinical Science Program and earned a Masters of Medical Science Degree from HMS in 2003. She holds board certifications in Cardiovascular Disease from the ABIM as well as Comprehensive Certification in Echocardiography from the NBE. She is a fellow of both the American College of Cardiology and the American Society of Echocardiography.
Her clinical interests include general clinical cardiology, valve disease, cardiomyopathy, structural heart diease and cardiovascular disease in Women. Her research interests include refining the role of echocardiography as a tool to better understand uncommon cardiomyopathies including Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy. She managed the Echo Core Lab for the Multidisciplinary Study of ARVC and participated with a group of experts who proposed Modifications of the original Task Force Criteria for the diagnosis of ARVC. She holds the adminstrative and teaching role in MGH's Cardiology Fellowship as the Medical Director of the Paul Dudley White Associates.
ResearchDr. Sanborn's research interests include defining and refining the role of echocardiography as a tool to better understand uncommon cardiomyopathies including Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy. She managed the Echo Core Lab for the North American Multidisciplinary Study of ARVC and participated with a group of experts who proposed Modifications of the original Task Force Criteria for the diagnosis of ARVC, published in 2010. She has also used her expertise in echocardiography to collaborate with colleagues at MGH who study the genetic basis of cardiovascular disease including atrial fibrillation and cardiomyopathy.
Publications
View my most recent publications at PubMed
Yoerger, DM, Marcus, F, et al, Echocardiographic Findings in Patients Meeting Task Force Criteria for Arrhythmogenic Right Ventricular Dysplasia JACC, 2005; 45: 860-65.
Yoerger DM, Picard, MH, et al. Time Course of Pressure Gradient Response After First Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol, 2006; 97:1511-14
Marcus FI, McKenna WJ, et al. Diagnosis of ARVC/D; Proposed modification of the Task Force Criteria. Circulation 2010
1. Chen AA, Palacios IF et al. Acute Predictors of Subacute Complete Heart Block After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol, 2006;97:264-269.
6. Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM. Sustained Improvement in Left Ventricular Diastolic Function after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Eur Heart J. 2006 Aug;27(15):1805-10.
MGH Hotline 2.18.11 Just in time for Valentine’s Day, the MGH Heart Center and Corrigan Women’s Heart Health Program brought attention to hearts everywhere by celebrating “Go Red for Women” month with a series of events and activities to raise awareness of heart disease in women.
Phone: 617-726-1543
Fax: 617-726-7684
Phone: 617-726-1543
Fax: 617-726-7684